BioFluidica, Inc.

About

BioFluidica, Inc. is a biotechnology and liquid biopsy company founded in 2006 and based in San Diego, California. The company specializes in developing innovative platforms for detecting and analyzing disease biomarkers through liquid biopsy technology. Its primary product, the LiquidScan Processing Module, is a fully automated microfluidic platform that isolates and enriches rare cells and exosomes from liquid biopsy samples, including whole blood, plasma, urine, and saliva. The LiquidScan platform utilizes advanced microfluidics and immunoaffinity chemistries to achieve high sensitivity in biomarker detection. BioFluidica offers two operational models: equipment sales for client facilities and fee-for-service processing through their Core Labs. Their services include rare cell isolation, circulating tumor cell isolation, fetal cell isolation, and exosome isolation. The company primarily focuses on oncology and prenatal diagnostics, providing valuable insights through blood tests and research applications.